Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AngioClast

AngioClast?uq=UG6efJS6
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Owner and operator of a biotechnology company. The company is focused on developing anti-cancer drugs for the treatment of brain cancer by utilizing molecular techniques.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • University of Cambridge
  • Cambridge
  • England
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AngioClast’s full profile, request a free trial.

AngioClast Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AngioClast Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Accelerate Cambridge Accelerator/Incubator 000 0000 000000 0

AngioClast Executive Team (2)

Name Title Board
Seat
Contact
Info
Juba Tsuladze Co-Founder & Chief Executive Officer
Tomoki Otani Ph.D Co-Founder